SCHEMBL5328615

SCHEMBL5328615

CC1CC(C)CN(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427405 0.86 — —
SCHEMBL21338973 0.83 — —
SCHEMBL21338975 0.83 — —
SCHEMBL20181185 0.83 — —
SCHEMBL22332820 0.77 — —
SCHEMBL22810507 0.77 — —
SCHEMBL21339456 0.75 ALDH1A1 (0.31) —
SCHEMBL19573813 0.72 — —
SCHEMBL22812881 0.72 — —
SCHEMBL19573970 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147382-A1 BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2021-05-20 — — US disclosed
WO-2007144512-A2 DIAZENIUMDIOLATE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF, AND USE OF SAME IN THE FIELDS OF HYPERTENSION AND CARDIOVASCULAR PATHOLOGIES LES LABORATOIRES SERVIER (FR) 2007-12-21 — — WO disclosed
Send feedback